Finch Therapeutics Group (FNCH) Short Interest Ratio & Short Volume → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free FNCH Stock Alerts $2.19 -0.17 (-7.20%) (As of 10:39 AM ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Finch Therapeutics Group Short Interest DataCurrent Short Volume9,200 sharesPrevious Short Volume11,600 sharesChange Vs. Previous Month-20.69%Dollar Volume Sold Short$23,920.92Short Interest Ratio / Days to Cover0.5Last Record DateMarch 31, 2024Outstanding Shares1,610,000 sharesFloat Size541,000 sharesShort Percent of Float1.70%Today's Trading Volume7,994 sharesAverage Trading Volume28,246 sharesToday's Volume Vs. Average28% Short Selling Finch Therapeutics Group ? Sign up to receive the latest short interest report for Finch Therapeutics Group and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatFNCH Short Interest Over TimeFNCH Days to Cover Over TimeFNCH Percentage of Float Shorted Over Time Ad Weiss RatingsThe only accurate crypto trading system I know …Juan Villaverde is no ordinary crypto trader. His proprietary timing algorithm has led him to rack up a series of gains of 477%, 333% and 153% on Bitcoin … It pointed the way to Cardano, at just 4 cents …Helping investors make 29 times their money.Here's what our expert says you should buy before April 14. Finch Therapeutics Group Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20249,200 shares $23,920.92 -20.7%1.7%0.5 $2.60 3/15/202411,600 shares $29,638.00 +383.3%2.2%0.6 $2.56 2/29/20242,400 shares $6,240.00 -27.3%0.5%0.1 $2.60 2/15/20243,300 shares $8,250.00 +65.0%0.6%0.1 $2.50 1/31/20242,000 shares $5,500.00 +300.0%0.4%0.1 $2.75 1/15/2024500 shares $1,555.00 -73.7%0.1%0 $3.11 Get the Latest News and Ratings for FNCH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Finch Therapeutics Group and its competitors with MarketBeat's FREE daily newsletter. 12/31/20231,900 shares $6,859.00 -65.5%0.4%0.1 $3.61 12/15/20235,500 shares $18,920.00 -61.3%1.0%0.3 $3.44 11/30/202314,200 shares $61,060.00 -27.9%2.5%1.7 $4.30 11/15/202319,700 shares $78,997.00 -3.9%3.4%2.8 $4.01 10/31/202320,500 shares $79,540.00 -11.6%3.6%2.8 $3.88 10/15/202323,200 shares $103,936.00 -4.1%4.1%2.6 $4.48 9/30/202324,200 shares $125,356.00 -15.1%4.3%2.5 $5.18 9/15/202328,500 shares $163,590.00 +27.2%5.1%2.7 $5.74 8/31/202322,400 shares $144,704.00 +4.7%4.0%0.6 $6.46 8/15/202321,400 shares $133,964.00 +57.4%3.8%0.6 $6.26 7/31/202313,600 shares $104,176.00 -20.0%0.1%0.4 $7.66 7/15/202317,000 shares $155,890.00 -25.4%0.1%0.5 $9.17 6/30/202322,800 shares $194,484.00 -20.8%4.0%0.6 $8.53 6/15/202328,800 shares $249,120.00 -73.1%5.1%0.8 $8.65 5/31/2023106,900 shares $897,960.00 +73.5%0.6%0.4 $8.40 5/15/202361,600 shares $22,268.40 -73.3%0.4%0.2 $0.36 4/30/2023230,300 shares $92,856.96 +83.1%1.4%0.8 $0.40 4/15/2023125,800 shares $49,363.92 +47.0%0.7%0.4 $0.39 3/31/202385,600 shares $33,640.80 -9.9%0.5%0.5 $0.39 3/15/202395,000 shares $35,150.00 -51.7%0.6%0.5 $0.37 2/28/2023196,500 shares $81,351.00 +10.2%1.2%1.2 $0.41 2/15/2023178,400 shares $75,124.24 +49.8%1.1%1.1 $0.42 1/31/2023119,100 shares $59,550.00 -4.4%0.7%0.9 $0.50 1/15/2023124,600 shares $69,776.00 +22.4%0.8%1.2 $0.56 12/30/2022101,800 shares $48,864.00 +27.4%0.6%1.4 $0.48 12/15/202279,900 shares $64,711.01 +6.4%0.5%1.3 $0.81 11/30/202275,100 shares $73,605.51 -17.7%0.5%1.8 $0.98 11/15/202291,300 shares $98,439.66 -17.9%0.6%2.1 $1.08 10/31/2022111,200 shares $144,560.00 -6.1%0.7%2.5 $1.30 10/15/2022118,400 shares $188,256.00 -21.0%0.7%2.6 $1.59 9/30/2022149,900 shares $250,333.00 +19.6%1.0%3.2 $1.67 9/15/2022125,300 shares $334,551.00 -12.7%0.8%2 $2.67 8/31/2022143,600 shares $310,176.00 -37.9%1.0%2 $2.16 8/15/2022231,400 shares $647,920.00 -19.6%1.5%2.8 $2.80Bitcoin Rockets To Record High But Buy THIS Instead (Ad)Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is. FNCH Short Interest - Frequently Asked Questions What is Finch Therapeutics Group's current short interest? Short interest is the volume of Finch Therapeutics Group shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 9,200 shares of FNCH short. 1.70% of Finch Therapeutics Group's shares are currently sold short. Learn More on Finch Therapeutics Group's current short interest. Which institutional investors are shorting Finch Therapeutics Group? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Finch Therapeutics Group: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Finch Therapeutics Group? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.70% of Finch Therapeutics Group's floating shares are currently sold short. Is Finch Therapeutics Group's short interest increasing or decreasing? Finch Therapeutics Group saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 9,200 shares, a decrease of 20.7% from the previous total of 11,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Finch Therapeutics Group's float size? Finch Therapeutics Group currently has issued a total of 1,610,000 shares. Some of Finch Therapeutics Group's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Finch Therapeutics Group currently has a public float of 541,000 shares. How does Finch Therapeutics Group's short interest compare to its competitors? 1.70% of Finch Therapeutics Group's shares are currently sold short. Here is how the short interest of companies compare to Finch Therapeutics Group: Palisade Bio, Inc. (0.21%), Fresh Tracks Therapeutics, Inc. (0.17%), 22nd Century Group, Inc. (5.58%), TRACON Pharmaceuticals, Inc. (32.67%), Avalon GloboCare Corp. (1.74%), Titan Pharmaceuticals, Inc. (0.59%), Creative Medical Technology Holdings, Inc. (2.17%), Gamida Cell Ltd. (7.11%), Windtree Therapeutics, Inc. (0.54%), BioCardia, Inc. (1.99%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Finch Therapeutics Group stock? Short selling FNCH is an investing strategy that aims to generate trading profit from Finch Therapeutics Group as its price is falling. FNCH shares are trading down $0.17 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Finch Therapeutics Group? A short squeeze for Finch Therapeutics Group occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of FNCH, which in turn drives the price of the stock up even further. How often is Finch Therapeutics Group's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FNCH, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: PALI Short Squeeze FRTX Short Squeeze XXII Short Squeeze TCON Short Squeeze ALBT Short Squeeze TTNP Short Squeeze CELZ Short Squeeze GMDA Short Squeeze WINT Short Squeeze BCDA Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FNCH) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIThe #1 Crypto for 2024InvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsUrgent alert: open this for a huge profit potentialTimothy SykesHow Biden has already won 2024Porter & CompanyTop 5 AI Stocks to Buy for 2024Market Moving Trends